International guidelines at your fingertips

Venous thromboembolism (VTE) is an independent prognostic factor of death in patients with cancer and one of the leading causes of death after metastasis.

Healthcare professionals may underestimate the prevalence of VTE in patients with cancer: 50% of deceased cancer patients are found to have a VTE on autopsy, but only up to 20% of patients with cancer are diagnosed with a VTE.

Based on ISTH-endorsed international clinical practice guidelines published in 2016 – “International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer” – this app is intended for physicians and other healthcare professionals treating patients with cancer.